3rd Quarter - Report

TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC

Firm
Client
Income
—
Expenses
$570,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

H.R. 1432 - Preserve Access to Affordable Generics Act S. 316 - Preserve Access to Affordable Generics Act H.R. 1908 - Patent Reform Act of 2007 S. 1145 - Patent Reform Act of 2007 H.R. 1902 - Protecting Consumer Access to Generic Drugs Act S. 25 - To amend the Federal Food, Drug, and Cosmetic Act to establish requirements for certain petitions submitted to the Food and Drug Administration, and for other purposes. S. 3600 - Patent Reform Act of 2008

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.

LobbyistCovered position, as disclosed
DEBRA BARRETT —
DAVID SANDERS Patent & Trademark Office - Government Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 1432 (110th), S. 1145 (110th), S. 316 (110th), S. 25 (110th), H.R. 1908 (110th), S. 3600 (110th), H.R. 1902 (110th)

Health Issues HCR

Proposals relating to prescription drug anti-counterfeiting efforts. H.R. 5839 - Safeguarding America's Pharmaceuticals Act of 2008 S. 2029 - Physician Payments Sunshine Act

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.

LobbyistCovered position, as disclosed
DEBRA BARRETT —
ROBERT FALB Rep. Visclosky, LA & LD (until 1991)
DAVID SANDERS Patent & Trademark Office - Government Affairs

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 2029 (110th), H.R. 5839 (110th)

Budget/Appropriations BUD

President Bush FY 2008 Budget Request - $15.7 million dollars Generic Drugs User Fees. Matters relating to FDA Office of Generic Drugs funding. H.R. 3161 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2008 S. 1859 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2008

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.

LobbyistCovered position, as disclosed
DEBRA BARRETT —
DAVID SANDERS Patent & Trademark Office - Government Affairs

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 3161 (110th), S. 1859 (110th)

Pharmacy PHA

S. 623 - Access to Life-Saving Medicines Act S. 438 - Fair Prescription Drug Competition Act H.R. 806 - Fair Prescription Drug Competition Act H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 H.R. 5629 - The Pathway for Biologics Act H.R. 1038 - Access to Life-Saving Medicine Act S. 1505 - Affordable Biologics for Consumers Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3610 - Food and Drug Import Safety Act of 2007 S. 28 - To amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary. H.R. 3624 - Consumer Food Safety Act of 2007

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.

LobbyistCovered position, as disclosed
DEBRA BARRETT —
DAVID SANDERS Patent & Trademark Office - Government Affairs

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3610 (110th), S. 28 (110th), S. 1695 (110th), H.R. 5629 (110th), H.R. 3624 (110th), H.R. 806 (110th), S. 623 (110th), S. 438 (110th), S. 1505 (110th), H.R. 1956 (110th), H.R. 1038 (110th)

Trade (domestic/foreign) TRD

Matters relating to Israeli data exclusivity. Matters relating to pharmaceutical provisions in free trade agreements.

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.

LobbyistCovered position, as disclosed
DEBRA BARRETT —
DAVID SANDERS Patent & Trademark Office - Government Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

S. 1951 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3700 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3140 - Saving Our Community Pharmacies Act of 2007

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.

LobbyistCovered position, as disclosed
DEBRA BARRETT —
DAVID SANDERS Patent & Trademark Office - Government Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3140 (110th), H.R. 3700 (110th), S. 1951 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.